These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9877115)

  • 41. [Antihypertensive therapy and progression of renal failure].
    Mann J; Ritz E
    Fortschr Med; 1987 Dec; 105(36):709-12. PubMed ID: 3428834
    [No Abstract]   [Full Text] [Related]  

  • 42. [Pharmacotherapy and renal function in the aged].
    Fabre J
    Schweiz Rundsch Med Prax; 1973 Oct; 62(40):1183-90. PubMed ID: 4585245
    [No Abstract]   [Full Text] [Related]  

  • 43. Clinical evaluation of debrisoquin in the treatment of hypertension.
    Rosendorff C; Marsden CD; Cranston WI
    Arch Intern Med; 1968 Dec; 122(6):487-90. PubMed ID: 5721874
    [No Abstract]   [Full Text] [Related]  

  • 44. [Emergencies in nephrology].
    Schmidt P
    Wien Med Wochenschr; 1982 Aug; 132(15-16):355. PubMed ID: 7147985
    [No Abstract]   [Full Text] [Related]  

  • 45. [Clinical use of bethanidine sulphate (Betanidol)].
    Kokubu T; Ueda E; Hiwada K
    Naika Hokan; 1967 Oct; 14(10):305-8. PubMed ID: 5626604
    [No Abstract]   [Full Text] [Related]  

  • 46. [Treatment of renoparenchymal hypertension in chronic glomerulonephritis with normal and impaired renal function].
    Stefanov G; Tishkov I; Todorova L
    Vutr Boles; 1982; 21(5):49-53. PubMed ID: 7164406
    [No Abstract]   [Full Text] [Related]  

  • 47. [Medico-social aspects of arterial hypertension and clinical considerations on its treatment with the guanoxane-polythiazide combination].
    Di Benedetto A; Di Blasi S
    Minerva Med; 1967 Mar; 58(21):893-6. PubMed ID: 6026542
    [No Abstract]   [Full Text] [Related]  

  • 48. Prevention of end-stage renal disease: a focus of antihypertensive therapy.
    Weir MR; Josselson J
    Md Med J; 1988 May; 37(5):369-72. PubMed ID: 3386421
    [No Abstract]   [Full Text] [Related]  

  • 49. What is the best treatment for slowing the progression to end-stage renal disease (ESRD) in African Americans with hypertensive nephropathy?
    McConaghy JR
    J Fam Pract; 2001 Sep; 50(9):744. PubMed ID: 11674903
    [No Abstract]   [Full Text] [Related]  

  • 50. Making an earlier diagnosis of ADPKD: implications for the treatment of hypertension.
    Perrone R; Miskulin DC
    Nephrol News Issues; 2006 Jun; 20(7):32, 35-6. PubMed ID: 16764142
    [No Abstract]   [Full Text] [Related]  

  • 51. [Effect of hypotensive therapy on kidney function in hypertensive states].
    Shershnev VG; Shcherban' NN; Gorodetskiĭ AL
    Ter Arkh; 1973 Oct; 45(10):85-8. PubMed ID: 4783250
    [No Abstract]   [Full Text] [Related]  

  • 52. Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease.
    Ruilope LM; Aldigier JC; Ponticelli C; Oddou-Stock P; Botteri F; Mann JF
    J Hypertens; 2000 Jan; 18(1):89-95. PubMed ID: 10678548
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Clinical observations on the treatment of arterial hypertension with a new drug of a guanidine type: cyclazenine].
    Montagnani M; Bayelli PF; Antonelli A; Barducci O
    Clin Ter; 1968 Sep; 46(5):419-38. PubMed ID: 5747193
    [No Abstract]   [Full Text] [Related]  

  • 54. [Conservative therapy of reno-vascular hypertension].
    Bock KD; Debusmann ER; Messer B
    Arch Klin Med; 1968; 215(3):229-43. PubMed ID: 5714028
    [No Abstract]   [Full Text] [Related]  

  • 55. [Pathogenesis and treatment of hypertension associated with chronic renal failure].
    Weidmann P; Beretta-Piccoli C
    Ther Umsch; 1982 May; 39(5):384-90. PubMed ID: 7101218
    [No Abstract]   [Full Text] [Related]  

  • 56. [Clinical experiences with a new antihypertensive agent].
    Lieb W; Ridders K
    Arzneimittelforschung; 1966 Dec; 16(12):1610-5. PubMed ID: 6014793
    [No Abstract]   [Full Text] [Related]  

  • 57. Guanoxan (compound 1003) in the treatment of hypertension.
    Ozen MA; Kadiglu A
    Curr Ther Res Clin Exp; 1965 Sep; 7(9):548-57. PubMed ID: 4953855
    [No Abstract]   [Full Text] [Related]  

  • 58. [Hypertension in patients with chronic renal disease].
    Laville M
    Rev Prat; 2004 Mar; 54(6):641-5. PubMed ID: 15222616
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Prolonged treatment of arterial hypertension with sympathetic inhibitors].
    Capris TA; Fernández Moores AJ; Cosentino JJ
    Medicina (B Aires); 1967; 27(1):27-36. PubMed ID: 5594902
    [No Abstract]   [Full Text] [Related]  

  • 60. [Usefulness of ultrasonographic renal resistive index in monitoring efficacy of hypotensive in haemodialysed patients--case report].
    Lubas A; Wańkowicz Z
    Pol Merkur Lekarski; 2002 Nov; 13(77):403-5. PubMed ID: 12621759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.